Exane Derivatives’s Compañía de Minas Buenaventura BVN Stock Holding History

Exane Derivatives’s Portfolio BVN Stock Details BVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$13	–	685
2018 Q3	$13	Hold	1	–	–	﹤0.01%	684
2018 Q2	$14	Hold	1	–	–	﹤0.01%	676
2018 Q1	$15	Hold	1	–	–	﹤0.01%	615
2017 Q4	$14	Hold	1	–	–	﹤0.01%	600
2017 Q3	$13	Sell	1 -1	-50%	-$13	﹤0.01%	563
2017 Q2	$23	Hold	2	–	–	﹤0.01%	613
2017 Q1	$24	Sell	2 -26	-93%	-$335	﹤0.01%	544
2016 Q4	$316	Sell	28 -6	-18%	-$72	﹤0.01%	498
2016 Q3	$471	Sell	34 -1,439	-98%	-$20.1K	﹤0.01%	492
2016 Q2	$17.6K	Sell	1,473 -225,136	-99%	-$2.18M	﹤0.01%	340
2016 Q1	$1.67M	Sell	226,609 -172,706	-43%	-$870K	0.22%	65
2015 Q4	$1.71M	Sell	399,315 -42,853	-10%	-$243K	0.23%	62
2015 Q3	$2.64M	Buy	442,168 +215,352	+95%	+$1.54M	0.33%	54
2015 Q2	$2.35M	Buy	226,816 +93,177	+70%	+$1.02M	0.25%	59
2015 Q1	$1.35M	Sell	133,639 -90,542	-40%	-$975K	0.15%	76
2014 Q4	$2.14M	Buy	+224,181	New	+$2.27M	0.3%	66

Other funds holding BVN

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Oldfield Partners London, United Kingdom $415M AUM 35.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Exane Derivatives's BVN Position: Q4 2018 in Review

Exane Derivatives sold out of Compañía de Minas Buenaventura (BVN) in Q4 2018, closing a stake of 1 share — an estimated $13 sold.

Exane Derivatives first reported a position in BVN in Q4 2014 and held it in 16 quarters. The position peaked at $2.64M in Q3 2015. 154 funds tracked by Wall St. Rank hold BVN as of Q4 2018.

Exane Derivatives reported no remaining Compañía de Minas Buenaventura position as of Q4 2018 after selling out during the quarter.
Exane Derivatives sold 1 Compañía de Minas Buenaventura share in Q4 2018, an estimated $13.
Exane Derivatives first reported a position in Compañía de Minas Buenaventura in Q4 2014 and held it in 16 quarters.
Exane Derivatives's Compañía de Minas Buenaventura position peaked at $2.64M in Q3 2015.
154 funds tracked by Wall St. Rank held Compañía de Minas Buenaventura as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.